Embolism Concept

Vocabulary Service

MeSH

Overview

subject area of

A Comparison of Aspirin with Placebo in Patients Treated with Warfarin after Heart-Valve Replacement Academic Article
Anticoagulant therapy following acute myocardial infarction. Part I. Incidence of and factors predisposing to thromboembolism associated with acute myocardial infarction. Academic Article
Anticoagulants in pregnancy: A review of indications and complications Academic Article
Anticoagulation therapy in 2015: where we are and where we are going Academic Article
Apixaban in Patients with Atrial Fibrillation Academic Article
Atrial fibrillation, moderate chronic kidney disease, and stroke prevention: new anticoagulants, new hope Academic Article
Berzelius Symposium 93: International Conference on Thrombosis and Embolism Academic Article
Cardiovascular Outcomes According to Polypharmacy and Drug Adherence in Patients with Atrial Fibrillation on Long-Term Anticoagulation (from the RE-LY Trial) Academic Article
Cholesterol microembolization syndrome Academic Article
Clinical pathologic conference Academic Article
Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation in real-world practice: a population-based cohort study protocol Academic Article
Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation: A retrospective cohort study Academic Article
Comparing mortality in patients with atrial fibrillation who are receiving a direct-acting oral anticoagulant or warfarin: a meta-analysis of randomized trials Academic Article
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials Academic Article
Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial Academic Article
Coronary Atheroembolism Academic Article
Cotton fibre embolism during angiography Academic Article
D-dimer and factor VIIa in atrial fibrillation – prognostic values for cardiovascular events and effects of anticoagulation therapy Academic Article
Dabigatran and Warfarin in Vitamin K Antagonist–Naive and –Experienced Cohorts With Atrial Fibrillation Academic Article
Dabigatran for stroke prevention in atrial fibrillation: the RE-LY trial Academic Article
Dabigatran versus Warfarin in Patients with Atrial Fibrillation Academic Article
Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada Academic Article
Definition of High Risk/High Response Population for Stroke in Patients with Transient Ischemic Attacks Academic Article
Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies Academic Article
Disseminated Tumor Embolism From Breast Cancer Leading to Multiorgan Failure Academic Article
Does activated protein C resistance increase the risk of systemic embolism in non rheumatic atrial fibrillation? Academic Article
Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT Academic Article
Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation Academic Article
Edoxaban versus Warfarin in Patients with Atrial Fibrillation Academic Article
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation Academic Article
Effect of apixaban on brain infarction and microbleeds: AVERROES-MRI assessment study Academic Article
Effectiveness and safety of rivaroxaban vs. warfarin in non-valvular atrial fibrillation patients with a non-sex-related CHA2DS2-VASc score of 1 Academic Article
Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation Academic Article
Efficacy and Safety of Dabigatran Compared to Warfarin in Patients With Paroxysmal, Persistent, and Permanent Atrial Fibrillation Academic Article
Efficacy and Safety of Dabigatran Etexilate vs. Warfarin in Asian RE-LY Patients According to Baseline Renal Function or CHADS₂ Score Academic Article
Efficacy and Safety of the Novel Oral Anticoagulants in Atrial Fibrillation Academic Article
Embolic strokes of undetermined source: Prevalence and patient features in the ESUS Global Registry Academic Article
Extracranial Systemic Embolic Events in Patients With Nonvalvular Atrial Fibrillation Academic Article
Heparin-induced thrombocytopenia: a historical perspective Academic Article
How Should Results from Completed Studies Influence Ongoing Clinical Trials? Academic Article
Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF‐TIMI 48 Trial Academic Article
Incorporating edoxaban into the choice of anticoagulants for atrial fibrillation Academic Article
Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale Academic Article
Infarto agudo de miocardio de causa no aterosclerótica: embolismo coronario Academic Article
Influence of low-intensity warfarin treatment on patients' perceptions of quality of life Academic Article
Intra-arterial low-dose streptokinase infusion for superior mesenteric artery embolus. Academic Article
Investigation of the Mechanism of False Positive125I-Labelled Fibrinogen Scans Academic Article
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation Academic Article
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke Academic Article
Linking Endogenous Factor Xa Activity, a Biologically Relevant Pharmacodynamic Marker, to Edoxaban Plasma Concentrations and Clinical Outcomes in the ENGAGE AF-TIMI 48 Trial Academic Article
Major Gastrointestinal Bleeding Often Is Caused by Occult Malignancy in Patients Receiving Warfarin or Dabigatran to Prevent Stroke and Systemic Embolism From Atrial Fibrillation Academic Article
Mechanical left atrial appendage closure was noninferior and superior to warfarin in atrial fibrillation Academic Article
Myocardial infarction size from serial CPK: variability of CPK serum entry ratio with size and model of infarction. Academic Article
Newly Identified Events in the RE-LY Trial Academic Article
Outcomes associated with non-recommended dosing of rivaroxaban: results from the XANTUS study Academic Article
Perioperative myocardial infarction caused by atheroembolism Academic Article
Preventing Cardioembolic Stroke in Atrial Fibrillation with Dabigatran Academic Article
RANDOMISED COMPARISON OF TWO INTENSITIES OF ORAL ANTICOAGULANT THERAPY AFTER TISSUE HEART VALVE REPLACEMENT Academic Article
Renal lesions and rise in blood pressure caused by adenosine diphosphate-induced platelet aggregation in rabbits. Academic Article
Response to Letter Regarding Article “Temporal Relationship Between Subclinical Atrial Fibrillation and Embolic Events” Academic Article
Review: Novel oral anticoagulants reduce stroke more than ASA in nonvalvular atrial fibrillation Academic Article
Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES Academic Article
Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: An exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials Academic Article
Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation Academic Article
Secondary Stroke Prevention in Cryptogenic Stroke and Embolic Stroke of Undetermined Source (ESUS) Academic Article
Spontaneous cholesterol embolisation: A rare cause of bowel infarction Academic Article
Stroke Risk and Efficacy of Apixaban in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease Academic Article
Subclinical Atrial Fibrillation and the Risk of Stroke Academic Article
Temporal Relationship Between Subclinical Atrial Fibrillation and Embolic Events Academic Article
The Challenge of Timing Surgery in a Complex Case of Endocarditis Academic Article
The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients Academic Article
The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation Academic Article
The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study Academic Article
The Warfarin and Antiplatelet Therapy in Heart Failure Trial (WATCH): rationale, design, and baseline patient characteristics Academic Article
Thrombosis and embolism in pediatric cardiomyopathy Academic Article
Unilateral digital ischaemia secondary to embolisation from subclavian atheroma. Academic Article
Utilization of fogarty arterial embolectomy catheter in urethral diverticulectomy Academic Article
Variation in Warfarin Dose Adjustment Practice Is Responsible for Differences in the Quality of Anticoagulation Control Between Centers and Countries Academic Article
Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: a randomized feasibility trial Academic Article
Warfarin and Aspirin after Heart-Valve Replacement Academic Article
Warfarin and acetaminophen interaction: a summary of the evidence and biologic plausibility Academic Article
‘Real world’ use of non-vitamin K antagonist oral anticoagulants (NOACs): Lessons from the Dresden NOAC Registry Academic Article